Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2
about
Beyond D-luciferin: expanding the scope of bioluminescence imaging in vivoBioluminescence imaging in live cells and animals.A review of novel optical imaging strategies of the stroke pathology and stem cell therapy in strokeMBL-II-141, a chromone derivative, enhances irinotecan (CPT-11) anticancer efficiency in ABCG2-positive xenograftsAltered glycaemia differentially modulates efflux transporter expression and activity in hCMEC/D3 cell line.Molecular Imaging of Membrane Transporters' Activity in Cancer: a Picture is Worth a Thousand Tubes.The Inhibitor Ko143 Is Not Specific for ABCG2The protein phosphatase 2A inhibitor LB100 sensitizes ovarian carcinoma cells to cisplatin-mediated cytotoxicityIn Vivo Imaging of Human MDR1 Transcription in the Brain and Spine of MDR1-Luciferase Reporter Mice.Bioluminescent imaging of ABCG2 efflux activity at the blood-placenta barrierThe Drug Excipient Cyclodextrin Interacts With d-Luciferin and Interferes With Bioluminescence ImagingNilotinib Effects in Parkinson's disease and Dementia with Lewy bodies.Imaging transporters: Transforming diagnostic and therapeutic development.In vivo bioluminescence imaging of neurogenesis - the role of the blood brain barrier in an experimental model of Parkinson's disease.Efflux proteins at the blood-brain barrier: review and bioinformatics analysis.Influence of breast cancer resistance protein and P-glycoprotein on tissue distribution and excretion of Ko143 assessed with PET imaging in mice.In Vivo Bioluminescent Imaging of ATP-Binding Cassette Transporter-Mediated Efflux at the Blood-Brain Barrier.
P2860
Q27026277-F600A3F7-346B-4355-8113-58B62246106BQ30759788-D8616A38-5764-4B6D-86DA-F36146F3148AQ30846905-5B869B6C-64FC-4203-82C7-465F8B2BCD82Q35068041-B74142EF-2AFE-4295-9138-A504FC4315E8Q35685226-6BF0AAFB-052D-4BE0-9B20-8CCBDE844B61Q35768413-3D2FD521-8580-4C9A-B6D1-1BA12EC0B17DQ35962045-C3118C72-1A84-4D13-88FD-8FD35654E4D4Q36019903-4D0BEF50-8F9A-41EE-8E5D-2B8810C048D8Q36186153-C58F5320-F12D-420D-99B6-6640FDD1420BQ36555565-AE019B55-F58E-4997-8B57-E7390D3143ECQ37170669-415BABE4-F495-46F1-9DE9-46A44BBE49DBQ37225128-58B1A184-869A-4195-A7EA-73D3789FE89DQ38871905-54F803FC-05DA-46F7-9DE6-313FDD068635Q38962780-A19BD531-2231-4482-B186-802FCDE53D0EQ39290800-C164D2AE-79C6-4C8C-B9C1-A78E1D7500A8Q47845084-EB0DCD84-605E-4938-8EE7-EF1E769D117CQ48619564-B3D8B784-AA00-40A5-852B-B1FEB08D2F0B
P2860
Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bioluminescent imaging of drug ...... iated by the transporter ABCG2
@en
Bioluminescent imaging of drug ...... ated by the transporter ABCG2.
@nl
type
label
Bioluminescent imaging of drug ...... iated by the transporter ABCG2
@en
Bioluminescent imaging of drug ...... ated by the transporter ABCG2.
@nl
prefLabel
Bioluminescent imaging of drug ...... iated by the transporter ABCG2
@en
Bioluminescent imaging of drug ...... ated by the transporter ABCG2.
@nl
P2093
P2860
P356
P1476
Bioluminescent imaging of drug ...... iated by the transporter ABCG2
@en
P2093
Bih-Rong Wei
Ki-Eun Chang
Matthew D Hall
Michael M Gottesman
R Mark Simpson
Suneet Shukla
Suresh V Ambudkar
P2860
P304
20801-20806
P356
10.1073/PNAS.1312159110
P407
P577
2013-12-02T00:00:00Z